Source: Eur Respir J 2016; 48: 1500-1503



Rating:

Share or cite this content

Citations should be made in the following way:
Zhiyi Lan, Mayara Bastos and Dick Menzies. Treatment of human disease due to Mycobacterium bovis: a systematic review. Eur Respir J 2016; 48: 1500-1503

Member's Comments

No comment yet.

Related content which might interest you: Contact investigation for tuberculosis: a systematic review and meta-analysis Source: Eur Respir J 2013; 41: 140-156 Year: 2013 Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis Source: Eur Respir J, 50 (4) 1701044; 10.1183/13993003.01044-2017 Year: 2017 Mycobacterium abscessus infection in lung transplant patients: review of our series Source: Annual Congress 2007 - Complications and success in lung transplantation Year: 2007 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis Source: Eur Respir J 2011; 37: 88-99 Year: 2011 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018 Year: 2019 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017 Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Miliary tuberculosis: a clinical review Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 On the nature of Mycobacterium tuberculosis-latent bacilli Source: Eur Respir J 2004; 24: 1044-1051 Year: 2004 Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis Source: Eur Respir J 2011; 37: 100-111 Year: 2011 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012